Our mission is to increase endometriosis awareness, fund landmark research, provide advocacy and support for patients, and educate the public and medical community.
Founders: Padma Lakshmi, Tamer Seckin, MD
×
Donate Now

EndoFound Research Grants

 HELP US FIND OUT MORE ABOUT ENDOMETRIOSIS

Give back by helping us fund endometriosis research today!

 DONATE TO RESEARCH

2023 Grant Recipients

Uterine NK cell dysfunction in endometriosis pathobiology

  • Dorien Feyaerts, PhD 
  • Brice Gaudilliere, MD, PhD
  • Linda Giudice, MD, PhD
  • Marina Sirota, PhD
  • Stanford University School of Medicine, CA, USA

Assessment of Reproductive Health Improvement in Endometriosis by novel STING inhibitors (ARIES)

  • Luis Villacorta, PhD, FAHA
  • Indrajit Chowdhuri, PhD 
  • Winston E. Thompson, PhD
  • Morehouse School of Medicine, Atlanta, GA 

Uterine adenomyosis: elucidating the etiopathogenesis and proposing new diagnostic biomarkers

  • Prof. Marie-Madeleine Dolmans, MD, PhD
  • Prof. Jacques Donnez, MD, PhD
  • Christina Anna Stratopoulou, MSc
  • Margherita Zipponi, MSc
  • Chloé Beaussart, MD, PhD 
  • Olivier Van Kerk 
  • Dolores Gonzalez
  • GYNE research laboratory, IREC, Université Catholique de Louvain

Modeling Endometriosis: Uncovering the Role of Dendritic Cells in Perpetuating Disease.

  • Elise Courtois, PhD
  • Nelio Oliveira, PhD
  • Joshua Lee, MD/PhD candidate
  • The Jackson Laboratory Foundation, Farmington, CT USA 06032

Define the Role of Humoral Immunity in the Pathophysiology of Endometriosis

  • Diane F. Jelinek, Ph.D. 
  • Dr. Khash Khazaie, Ph.D. 
  • Joseph Grande, M.D., Ph.D.
  • Karen Anderson M.D., Ph.D.  
  • Zaraq Khan, M.B.B.S., M.S.
  • Johnny Yi, M.D.
  • Megan Wasson, M.D.
  • Mayo Clinic Arizona


Disclaimer:

Endofound is a charitable entity and is not committed to matching the indirect cost rates of the U.S. government or other entities.  We believe our policy to allow no more than 10% of any Endofound research grant funding to go towards indirect costs is consistent with that of many private foundations and certain government entities that have a flat rate that caps the amount an applicant institution can charge. Endofound's policy helps ensure furtherance of our charitable purpose.